Protalix BioTherapeutics (PLX)
(Delayed Data from AMEX)
$1.07 USD
+0.13 (13.32%)
Updated Sep 3, 2024 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 34% (85 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.37 | 9.99 |
Current Quarter Estimate | 0.06 | 2.92 | 61.00 |
Year Ago Quarter Estimate | -0.04 | -4.86 | 54.84 |
Next Quarter Estimate | 0.10 | 3.90 | 63.00 |
Next Year Estimate | 0.62 | 25.15 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -33.33 | 17.60 | 15.67 |
Next Year | 933.33 | 9.50 | 11.34 |
Last 5 Years | NA | 0.90 | 8.10 |
Next 5 Years | NA | 21.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -6.80 |
Price/Book (MRQ) | 2.74 | 2.05 |
Price/Cash Flow (MRFY) | 7.84 | 17.40 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -38.62% | -147.72% |
Return on Equity (TTM) | -45.15% | -60.91% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.